Glenmede Trust CO Na Novavax Inc Transaction History

Glenmede Trust CO Na

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $140,505 - $287,943	-2,015 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$134.56 - $217.97 $1,749 - $2,833	-13 Reduced 0.64%	2,015 $288,000
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $1,600 - $2,435	9 Added 0.45%	2,028 $420,000
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $228,206 - $485,965	-1,886 Reduced 48.3%	2,019 $428,000
Q1 2021 May 18, 2021	SELL	$112.98 - $319.93 $118,629 - $335,926	-1,050 Reduced 21.19%	3,905 $708,000
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $179,290 - $317,641	2,277 Added 85.03%	4,955 $552,000
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $30,822 - $69,261	388 Added 16.94%	2,678 $290,000
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $31,739 - $191,466	2,290 New	2,290 $190,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.